ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD

Zhangzhou Pientzehuang Pharmaceutical., Ltd

600436

CNE000001F21

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
216.8 ^CNY	+2.98%		+8.65%	-10.41%

Jun. 21	Pientzehuang Pharmaceutical Gets Nod to Trails Lymphoma Drug	MT
Apr. 19	Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Zhangzhou Pientzehuang Pharmaceutical Co.,Ltd. Announces Resignation of Independent Directors

June 03, 2014 at 07:01 am EDT

Zhangzhou Pientzehuang Pharmaceutical Co.,Ltd. announced resignation of Lu Yonghua from position of Independent Director and Tong Jinzhi's Resignation from Position of Independent Director.

Latest news about Zhangzhou Pientzehuang Pharmaceutical., Ltd

Pientzehuang Pharmaceutical Gets Nod to Trails Lymphoma Drug	Jun. 21	MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. Signs Cooperation Agreement with Beijing Tong Ren Tang Group	Feb. 01	CI
Pientzehuang Pharmaceutical's Profit Climbs 12.6% in 2023	Jan. 31	MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 30	CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-16	CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-13	CI
Zhangzhou Pientzehuang to Raise Price of Multifunctional TCM by 29%	23-05-09	MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-14	CI
Pientzehuang Logs Slowest Profit Growth in 12 Years	23-01-31	MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-30	CI
Pien Tze Huang Pharma’s Q3 Profit Falls 18% as Revenue Slips 3%	22-10-25	MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-21	CI
FTSE Russell makes additions including PetroChina in review of China indices	22-08-31	RE
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-18	CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-22	CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-15	CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-15	CI
Market Chatter: Century-Old Chinese Companies Tap Into Stock Market to Fuel Growth	21-07-20	MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-16	CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-23	CI
Exclusive: Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TCM - sources	21-01-27	RE
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-23	CI
China stocks end lower as high-flying consumer shares retreat	20-09-03	RE
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-21	CI

Chart Zhangzhou Pientzehuang Pharmaceutical., Ltd

Duration

Period

Chart Zhangzhou Pientzehuang Pharmaceutical., Ltd

More charts

Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. is specialized in developing and marketing traditional Chinese medicine products. The company offers medicines and health products, cosmetic products, dietary compounds, etc.

Sector

Pharmaceuticals

Calendar

2024-08-16 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Zhangzhou Pientzehuang Pharmaceutical., Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

216.8 CNY

Average target price

281.3 CNY

Spread / Average Target

+29.76%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD	-10.41%	17.51B
ELI LILLY AND COMPANY	+63.17%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-3.99%	359B
MERCK & CO., INC.	+16.37%	325B
ABBVIE INC.	+9.03%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+15.61%	177B
PFIZER, INC.	+1.81%	165B

Other Pharmaceuticals

Zhangzhou Pientzehuang Pharmaceutical., Ltd

Equities

600436

CNE000001F21

Pharmaceuticals

Zhangzhou Pientzehuang Pharmaceutical Co.,Ltd. Announces Resignation of Independent Directors

Latest news about Zhangzhou Pientzehuang Pharmaceutical., Ltd

Chart Zhangzhou Pientzehuang Pharmaceutical., Ltd

Company Profile

Income Statement Evolution

Ratings for Zhangzhou Pientzehuang Pharmaceutical., Ltd

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals